Israeli startup CytoReason has made its entry into Japan – the world's third-largest pharmaceutical market, upon signing a collaboration with Summit Pharmaceuticals International, the drug research and development arm of Sumitomo Corporation, one of the world's biggest general trading firms.
WHAT THEY DO
CytoReason develops computational disease models for drug discovery and development using...
A landmark clinical trial has found that a new digital therapeutic app for hypertension is effective in reducing the risks of cardiovascular and cerebrovascular diseases.
Japanese medical technology startup CureApp collaborated with Jichi Medical University in the Tochigi Prefecture to conduct the third phase of the said clinical trial, which marks the world's first trial of a therapeutic app for...
Multinational medical imaging device maker Fujifilm Corporation has received the approval of Japan's Pharmaceuticals and Medical Devices Agency for its latest AI-powered chest x-ray software.
WHAT IT DOES
The Fujifilm CXR-AID detects major abnormal findings from chest radiographs, such as chest nodule, consolidation and pneumothorax.
Based on a press statement, the diagnostic system runs on...
New Jersey-based Otsuka Pharmaceutical Development & Commercialization has signed a three-year collaboration with Holmusk, a data science and digital health firm based in Singapore and New York. The deal is worth up to $4 million annually.
WHAT THEY DO
OPDC is an indirect unit of Otsuka Pharmaceutical Company, which is a subsidiary of Japan-based Otsuka Holdings. It develops and manufactures...
Omron Healthcare and Kyoto University are set to undertake a study under a joint research programme to use artificial intelligence and home-recorded health data in predicting early signs of cardiovascular diseases.
WHY IT MATTERS
In a press statement, Omron said their upcoming study under the Healthcare Medical AI research programme will focus on two themes: First, the development of a novel...
Aevice Health, a Singapore-based medical technology company, has raised S$2.8 million ($2.1 million) from a pre-Series A funding round participated by Toho Holdings, Pureland Group Venture, Silicon Solutions Partners, AIP Ventures and SEEDS Capital of Enterprise Singapore.
WHY IT MATTERS
A spin-off from Nanyang Technological University, Aevice Health creates non-invasive wearable devices that...
Japan-headquartered Atonarp has raised $50 million from a Series D funding round led by Silicon Valley-based investor WRVI Capital and supported by Furukawa Electric, Japan Post Investment, Boscolo Intervest, ATI Korea, and Banner Industries. This brings a total of $111 million in investments for the company.
WHAT IT DOES
Founded in 2010, Atonarp produces digital molecular diagnostic solutions...
Sysmex Corporation, a manufacturer of medical equipment and devices, has signed deals of joint development and investment with biotechnology startup ThinkCyte for the production and sale of a new artificial intelligence-enabled cell analysis technology for in-vitro diagnostics.
WHAT IT'S FOR
Sysmex has been acquiring technologies for analysing cells, genes, and proteins with a high degree of...
Taiwan-based diabetes management app Health2Sync and DAIKYO ASTAGE INCORPORATED, a Japan-based apartment management company, has partnered to provide health management services to residents in DAIKYO ASTAGE managed apartments in Japan.
The partnership also includes two local pharmacies, Primary Pharmacy Co., Ltd. and Yakuju Co., Ltd., and will commence in the city of Kawasaki City, Kanagawa...
San Francisco-based cognitive assessment app maker Savonix announced the launch of its Japanese website, Savnonix.jp. The website explains the science behind Savonix’s brain health platform.
It highlights ways the company can provide cognitive health and data insights to support people and companies in Japan to monitor brain health, understand risk factors for developing dementia and take steps...
